Regulation, Digitization Mulled As Swiss Medtechs Look To An ‘EU+’ Vision For The Future

Swiss Parliament addresses proposal to allow US FDA-approved products onto the market

With Switzerland now operating as a third country to the EU, Swiss-based medtech manufacturers are keen to maximize their inherent advantages and build a basis for future growth.

Shutterstock

The Swiss Medtech industry association used its 2022 annual meeting of members to lay out a new vision for the national medtech industry, proposing strategies that should lastingly strengthen the country’s attractiveness as a medtech business location.

The proposals, aired on 17 May under the banner “Medtech in Switzerland 2030,” set out a multi-point reform agenda designed to maximize local medtech business and innovation opportunities. The ideas...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Switzerland

More from Europe